An Aggressive Management Strategies for Acute Kidney Transplant Rejection: An Indonesian Tertiary Center Experience
Abstract
Acute kidney transplant rejection remains a major cause of early graft malfunction worldwide especially in low- and middle-income countries where diagnostic and treatment resources are limited. Global data indicate that 10–20% of recipients experience acute rejection within the first year, with higher rates reported in developing regions. This study examined the clinical attributes and outcomes of intensive therapy approaches for acute graft malfunction at Dr. Sardjito General Hospital in Yogyakarta, Indonesia. A retrospective case series included four adult kidney transplant recipients who developed acute graft malfunction within 30 days of transplantation (2024 - 2025), defined as a >25% rise in serum creatinine and/or oliguria. Demographic data, Doppler ultrasound resistive index (RI), immunosuppressive therapy, therapeutic plasma exchange (TPE), and short-term outcomes were analyzed descriptively. The study comprised three males and one female (aged 23 – 54 years old). All patients showed elevated RI (>0.75). TPE was performed in three cases (75%), resulting in two full recoveries, one partial recovery, and one persistent dysfunction due to combined immunological and surgical complications. Higher RI values were associated with more intensive treatment. These findings suggest that personalized aggressive therapies, such as TPE and intravenous immunoglobulin, may serve as viable salvage options for severe early graft malfunction. In resource-limited settings, Doppler ultrasound provides valuable non-invasive support when biopsy is unvailable. Larger multicenter studies are needed to confirm long-term efficacy and generalizability.
Keywords: Kidney Transplantation, Acute Rejection, Therapeutic Plasma Exchange, Doppler Ultrasound, Immunosuppression.
Full Text:
PDFReferences
Alasfar, S., Kodali, L., & Schinstock, C. A. (2023). Current Therapies in Kidney Transplant Rejection. Journal of Clinical Medicine, 12(15), 4927. https://doi.org/10.3390/jcm12154927
Alkan, F. T., Tatar, E., Karatas, M., Simsek, C., Tercan, I. C., Aykas, A., & Uslu, A. (2020). Response to treatment in kidney transplant recipients with acute antibody-mediated rejection: A follow-up biopsy study. Clinical Nephrology, 93(2), 85–90. https://doi.org/10.5414/CN109819
Anesi, J. (2022). Commentary: Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults—nine states, January–September 2021. American Journal of Transplantation, 22(1), 304–305. https://doi.org/10.1111/ajt.16910
Chandran, S., & Mannon, R. B. (2022). T cell–mediated rejection in kidney transplant recipients: The end(point) is also the beginning. American Journal of Transplantation, 22(3), 683–684. https://doi.org/10.1111/ajt.16964
Clayton, P. A., McDonald, S. P., Russ, G. R., & Chadban, S. J. (2019). Long-Term Outcomes after Acute Rejection in Kidney Transplant Recipients: An ANZDATA Analysis. Journal of the American Society of Nephrology, 30(9), 1697. https://doi.org/10.1681/ASN.2018111101
Coemans, M., Süsal, C., Döhler, B., Anglicheau, D., Giral, M., Bestard, O., Legendre, C., Emonds, M.-P., Kuypers, D., Molenberghs, G., Verbeke, G., & Naesens, M. (2018). Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015. Kidney International, 94(5), 964–973. https://doi.org/10.1016/j.kint.2018.05.018
Connolly, H., Watson, A., Wynd, M., Lieberman, K., Chaung, M., Goldstein, M. J., Hidalgo, G., Batal, I., Amoruso, M., & Jain, N. G. (2025). Daratumumab for Treatment of Acute Antibody-Mediated Rejection in a Pediatric Kidney Transplant Recipient. Pediatric Transplantation, 29(5), e70116. https://doi.org/10.1111/petr.70116
Cooper, J. E. (2020). Evaluation and Treatment of Acute Rejection in Kidney Allografts. Clinical Journal of the American Society of Nephrology : CJASN, 15(3), 430–438. https://doi.org/10.2215/CJN.11991019
Cornell, L. D. (2021). Histopathologic Features of Antibody Mediated Rejection: The Banff Classification and Beyond. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.718122
Doganci, M., Izdes, S., Cirik, M. O., Doganci, M., Izdes, S., & Cirik, M. O. (2023). The Evaluation of Risk Factors for Vancomycin-Resistant Enterococcus Colonization and Infection Among Mixed Adult Intensive Care Unit Patients. Cureus, 15(1). https://doi.org/10.7759/cureus.33210
Hariharan, S., Israni, A. K., & Danovitch, G. (2021). Long-Term Survival after Kidney Transplantation. New England Journal of Medicine, 385(8), 729–743. https://doi.org/10.1056/NEJMra2014530
Khudari, R. A., Doba, D., Esmandar, A., & Kheder, M. (2024). Treatment outcome at the pediatric stem cell transplantation center in Syria: A single-center experience. Pediatric Transplantation, 28(5), e14789. https://doi.org/10.1111/petr.14789
Koshy, P., Furian, L., Nickerson, P., Zaza, G., Haller, M., de Vries, A. P. J., & Naesens, M. (2024). European Survey on Clinical Practice of Detecting and Treating T-Cell Mediated Kidney Transplant Rejection. Transplant International: Official Journal of the European Society for Organ Transplantation, 37, 12283. https://doi.org/10.3389/ti.2024.12283
Leung, K. C., Ng, W. W. S., Ciofani, J., & Kwok, W. (2025). Survival of kidney transplantation in people living with HIV/AIDS: A systematic review and meta-analysis. BMC Infectious Diseases, 25(1), 1160. https://doi.org/10.1186/s12879-025-11480-7
Marbun, M. B. H., Susalit, E., Susilowati, U., & Andina, T. (2022). Long-term outcomes and prognostic factors in kidney transplant recipients in Jakarta, Indonesia: A cohort study. BMJ Open, 12(5), e059631. https://doi.org/10.1136/bmjopen-2021-059631
Moein, M., Papa, S., Ortiz, N., Saidi, R., Moein, M., Papa, S., Ortiz, N., & Saidi, R. (2023). Protocol Biopsy After Kidney Transplant: Clinical Application and Efficacy to Detect Allograft Rejection. Cureus, 15(2). https://doi.org/10.7759/cureus.34505
Mudiayi, D., Shojai, S., Okpechi, I., Christie, E. A., Wen, K., Kamaleldin, M., Elsadig Osman, M., Lunney, M., Prasad, B., Osman, M. A., Ye, F., Khan, M., Htay, H., Caskey, F., Jindal, K. K., Klarenback, S., Jha, V., Rondeau, E., Turan Kazancioglu, R., … Bello, A. K. (2022). Global Estimates of Capacity for Kidney Transplantation in World Countries and Regions. Transplantation, 106(6), 1113–1122. https://doi.org/10.1097/TP.0000000000003943
Naesens, M., Kuypers, D. R. J., & Sarwal, M. (2009). Calcineurin inhibitor nephrotoxicity. Clinical Journal of the American Society of Nephrology: CJASN, 4(2), 481–508. https://doi.org/10.2215/CJN.04800908
Naesens, M., Roufosse, C., Haas, M., Lefaucheur, C., Mannon, R. B., Adam, B. A., Aubert, O., Böhmig, G. A., Callemeyn, J., Groningen, M. C., Cornell, L. D., Demetris, A. J., Drachenberg, C. B., Einecke, G., Fogo, A. B., Gibson, I. W., Halloran, P., Hidalgo, L. G., Horsfield, C., … Mengel, M. (2024). The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics. American Journal of Transplantation, 24(3), 338–349. https://doi.org/10.1016/j.ajt.2023.10.016
Naik, R. H., Hassanein, M., & Shawar, S. H. (2025). Acute Renal Transplantation Rejection. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK553074/
Pittappilly, M., Sharshir, M., & Paramesh, A. (2025). Chronic Allograft Nephropathy—A Narrative Review of Its Pathogenesis, Diagnosis, and Evolving Management Strategies. Biomedicines, 13(4), 929. https://doi.org/10.3390/biomedicines13040929
Prabu, O. G., Hustrini, N. M., Marbun, M. B. H., Septianto, T., Indriani, A., Septiar, D., Lydia, A., Nugroho, P., & Susalit, E. (2022). Acute rejection associated with short-term and long-term survival in kidney transplantation: A single center study in Indonesia. Korean Journal of Transplantation, 36(1), 200–200. https://doi.org/10.4285/ATW2022.F-3342
Shabunin, A. V., Drozdov, P. A., Makeev, D. A., Nesterenko, I. V., Zhuravel, O. S., Karapetyan, L. R., Astapovich, S. A., & Lidzhieva, Е. A. (2023). Personalized dosing protocol for extended-release tacrolimus in kidney transplant recipients in the early postoperative period. Russian Journal of Transplantology and Artificial Organs, 25(1), 52–61. https://doi.org/10.15825/1995-1191-2023-1-52-61
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., Lamb, E., Lin, P., Madero, M., McIntyre, N., Morrow, K., Roberts, G., Sabanayagam, D., Schaeffner, E., Shlipak, M., … Levin, A. (2024). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International, 105(4), S117–S314. https://doi.org/10.1016/j.kint.2023.10.018
Surdi, L. M., Dagher, M., Merhej, T., Choi, J., & Azzi, J. R. (2025). Antibody-Mediated Rejection in Kidney Transplantation: Immunopathogenesis, Innate–Adaptive Crosstalk, and Therapeutic Advances. OBM Transplantation, 9(3), 1–44. https://doi.org/10.21926/obm.transplant.2503258
Tamargo, C. L., & Kant, S. (2023). Pathophysiology of Rejection in Kidney Transplantation. Journal of Clinical Medicine, 12(12), 4130. https://doi.org/10.3390/jcm12124130
Yeow, M., Soh, S., Wong, J., Tan, E., & Ganpathi Iyer, S. (2022). Gender Diversity in Transplantation Leadership Positions in Transplantation Journals and Organizations. Transplantation, 106(7), e352. https://doi.org/10.1097/TP.0000000000004123
Zhang, R. (2018). Donor-Specific Antibodies in Kidney Transplant Recipients. Clinical Journal of the American Society of Nephrology : CJASN, 13(1), 182–192. https://doi.org/10.2215/CJN.00700117
DOI: http://dx.doi.org/10.30829/contagion.v8i1.28176
Refbacks
- There are currently no refbacks.
Copyright (c) 2026 Yudriawan Annas, Trisula Utomo, Tanaya Ghinorawa
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
